GlassScriptPhysician profile
Sophia Ali
NPI 1750641007
$649.32
in general payments reported to CMS, 2019-2025
14 companies · $117 in 2025
The $117 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $317 · 2020: $137 · 2021: $78.12 · 2025: $117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $117.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $267.97 | 2019-2025 | Wegovy |
| Lilly USA, LLC | $71.47 | 2020 | |
| Horizon Therapeutics Plc | $65.00 | 2019 | |
| Amarin Pharma, INC. | $39.79 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $34.98 | 2025 | |
| Corcept Therapeutics | $28.44 | 2019 | |
| Valeritas, INC. | $25.44 | 2019 | |
| Abbott Laboratories | $22.61 | 2021 | |
| Amgen INC. | $18.88 | 2019 | |
| Becton, Dickinson and Company | $18.29 | 2019 | |
| Nestle Healthcare Nutrition INC. | $15.72 | 2021 | |
| Medtronic Minimed, INC. | $14.11 | 2019 | |
| Celgene Corporation | $13.57 | 2019 | |
| Sanofi-Aventis U.S. LLC | $13.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sophia Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.